Next Article in Journal
Antimicrobial Resistance (AMR) in the Food Chain: Trade, One Health and Codex
Next Article in Special Issue
Drug Discovery for Chagas Disease: Impact of Different Host Cell Lines on Assay Performance and Hit Compound Selection
Previous Article in Journal
Evaluation of a Virus Neutralisation Test for Detection of Rift Valley Fever Antibodies in Suid Sera
Open AccessPerspective

WIPO Re:Search: Catalyzing Public-Private Partnerships to Accelerate Tropical Disease Drug Discovery and Development

BIO Ventures for Global Health, 2101 Fourth Avenue, Suite 1950, Seattle, WA 98121, USA
*
Author to whom correspondence should be addressed.
Trop. Med. Infect. Dis. 2019, 4(1), 53; https://doi.org/10.3390/tropicalmed4010053
Received: 1 March 2019 / Revised: 20 March 2019 / Accepted: 22 March 2019 / Published: 26 March 2019
(This article belongs to the Special Issue Drug Discovery and Development for Tropical Diseases)
Tropical diseases, including malaria and a group of infections termed neglected tropical diseases (NTDs), pose enormous threats to human health and wellbeing globally. In concert with efforts to broaden access to current treatments, it is also critical to expand research and development (R&D) of new drugs that address therapeutic gaps and concerns associated with existing medications, including emergence of resistance. Limited commercial incentives, particularly compared to products for diseases prevalent in high-income countries, have hindered many pharmaceutical companies from contributing their immense product development know-how and resources to tropical disease R&D. In this article we present WIPO Re:Search, an international initiative co-led by BIO Ventures for Global Health (BVGH) and the World Intellectual Property Organization (WIPO), as an innovative and impactful public-private partnership model that promotes cross-sector intellectual property sharing and R&D to accelerate tropical disease drug discovery and development. Importantly, WIPO Re:Search also drives progress toward the United Nations Sustainable Development Goals (SDGs). Through case studies, we illustrate how WIPO Re:Search empowers high-quality tropical disease drug discovery researchers from academic/non-profit organizations and small companies (including scientists in low- and middle-income countries) to leapfrog their R&D programs by accessing pharmaceutical industry resources that may not otherwise be available to them. View Full-Text
Keywords: WIPO Re:Search; public-private partnerships; drug discovery; malaria; neglected tropical diseases; BIO Ventures for Global Health WIPO Re:Search; public-private partnerships; drug discovery; malaria; neglected tropical diseases; BIO Ventures for Global Health
Show Figures

Figure 1

MDPI and ACS Style

Manner, C.K.; Graef, K.M.; Dent, J. WIPO Re:Search: Catalyzing Public-Private Partnerships to Accelerate Tropical Disease Drug Discovery and Development. Trop. Med. Infect. Dis. 2019, 4, 53.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop